Graphite Oxide to Graphene. Biomaterials to Bionics
Source abstract
Abstract
The advent of implantable biomaterials has revolutionized medical treatment, allowing the development of the fields of tissue engineering and medical bionic devices (e.g., cochlea implants to restore hearing, vagus nerve stimulators to control Parkinson's disease, and cardiac pace makers). Similarly, future materials developments are likely to continue to drive development in treatment of disease and disability, or even enhancing human potential. The material requirements for implantable devices are stringent. In all cases they must be nontoxic and provide appropriate mechanical integrity for the application at hand. In the case of scaffolds for tissue regeneration, biodegradability in an appropriate time frame may be required, and for medical bionics electronic conductivity is essential. The emergence of graphene and graphene‐family composites has resulted in materials and structures highly relevant to the expansion of the biomaterials inventory available for implantable medical devices. The rich chemistries available are able to ensure properties uncovered in the nanodomain are conveyed into the world of macroscopic devices. Here, the inherent properties of graphene, along with how graphene or structures containing it interface with living cells and the effect of electrical stimulation on nerves and cells, are reviewed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Neuroscience and Neural Engineering · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Mechanical and Aerospace Engineering Nanyang Technological University 639798 Singapore
Institute for Sports Research Nanyang Technological University 639798 Singapore
Intelligent Polymer Research Institute ARC Center of Excellence for Electromaterials Science University of Wollongong 2500 Australia
Funding
Australian Research Council · Superscience Fellowship scheme
References (100+)
Show source-provided references
1. 10.1016/B978-012370615-7/50015-910.1016/B978-012370615-7/50015-9 ↗
2. 1995
3. International Standard ISO10993 “Biological Evaluation of Medical Devices” International Standards Organisation1997.
4. USFDACenter for Devices and Radiological Health Use of International Standard ISO‐10993 “Biological Evaluation of Medical Devices Part 1: Evaluation and Testing” ‐ Draft Guidance for Industry and Food and Drug Administration Staff US Food and Drug Administration Silver Springs MD USA2013.
5. USFDA website http://www.fda.gov/accessed:March2015.
6. 10.1128/mBio.00420-1210.1128/mBio.00420-12 ↗
7. 10.1073/pnas.77.2.120910.1073/pnas.77.2.1209 ↗
8. 10.1152/physrev.00020.200410.1152/physrev.00020.2004 ↗
9. 10.1179/2045772313Y.000000011710.1179/2045772313Y.0000000117 ↗
10. 10.1016/j.bbagen.2013.04.00710.1016/j.bbagen.2013.04.007 ↗
11. 10.1111/ejn.1237010.1111/ejn.12370 ↗
12. Koppes A. N. · Tissue Eng., Part A · 2014 · 20 · 494
13. 10.1152/jn.00806.201310.1152/jn.00806.2013 ↗
14. 10.1002/jnr.2336510.1002/jnr.23365 ↗
15. Zhang G. · Neural Regener. Res. · 2013 · 8 · 2531
16. 10.1007/s11916-014-0412-910.1007/s11916-014-0412-9 ↗
17. 10.1371/journal.pone.010231310.1371/journal.pone.0102313 ↗
18. 10.1016/j.annfar.2013.11.00710.1016/j.annfar.2013.11.007 ↗
19. 10.1016/j.pain.2014.06.02210.1016/j.pain.2014.06.022 ↗
20. 10.1371/journal.pone.010504510.1371/journal.pone.0105045 ↗
21. 10.1002/glia.2247610.1002/glia.22476 ↗
22. Aas V. · 2002 · 506
23. 10.1039/c2lc40479f10.1039/c2lc40479f ↗
24. 10.1002/cbf.111810.1002/cbf.1118 ↗
25. 10.1089/ten.tec.2011.036410.1089/ten.tec.2011.0364 ↗
26. 10.1042/bj321084510.1042/bj3210845 ↗
27. 10.2165/00007256-199213050-0000310.2165/00007256-199213050-00003 ↗
28. 10.1093/ptj/68.5.66010.1093/ptj/68.5.660 ↗
29. 10.1016/S0021-9258(18)77444-910.1016/S0021-9258(18)77444-9 ↗
30. 10.1002/jor.110014012110.1002/jor.1100140121 ↗
31. 10.1016/j.yexcr.2007.03.00210.1016/j.yexcr.2007.03.002 ↗
32. 10.1039/c3ra46218h10.1039/c3ra46218h ↗
33. 10.1002/adhm.20120010210.1002/adhm.201200102 ↗
34. 10.1016/j.fcl.2005.06.00610.1016/j.fcl.2005.06.006 ↗
35. 10.1016/j.mehy.2007.05.04410.1016/j.mehy.2007.05.044 ↗
36. Griffin M. · Eplasty · 2011 · 11 · e34
37. 10.1002/jor.2250510.1002/jor.22505 ↗
38. No More Fillings as Dentists Reveal New Tooth Decay Treatment (16/6/14) inThe Guardian http://www.theguardian.com/society/2014/jun/16/fillings‐dentists‐tooth‐decay‐treatment; accessed:July2014.
39. 10.1242/jcs.02356410.1242/jcs.023564 ↗
40. 10.1096/fj.04-2325com10.1096/fj.04-2325com ↗
41. 10.1016/j.biomaterials.2011.02.02410.1016/j.biomaterials.2011.02.024 ↗
42. 10.1152/ajpendo.00450.201310.1152/ajpendo.00450.2013 ↗
43. 10.1016/j.biomaterials.2006.11.02610.1016/j.biomaterials.2006.11.026 ↗
44. 10.1002/adfm.20110237310.1002/adfm.201102373 ↗
45. 10.1038/nn94710.1038/nn947 ↗
46. 10.1126/science.116834610.1126/science.1168346 ↗
47. 10.1002/adma.20130449610.1002/adma.201304496 ↗
48. 10.1021/tx200339h10.1021/tx200339h ↗
49. 10.1016/j.carbon.2014.04.08810.1016/j.carbon.2014.04.088 ↗
50. 10.1038/nnano.2007.45110.1038/nnano.2007.451 ↗
51. 10.1021/ar300199e10.1021/ar300199e ↗
52. 10.1016/j.carbon.2012.11.05810.1016/j.carbon.2012.11.058 ↗
53. 10.1073/pnas.122227611010.1073/pnas.1222276110 ↗
54. 10.1021/nn102430310.1021/nn1024303 ↗
55. 10.1016/j.biomaterials.2012.02.02110.1016/j.biomaterials.2012.02.021 ↗
56. 10.1021/am303005j10.1021/am303005j ↗
57. 10.1021/am300253c10.1021/am300253c ↗
58. 10.1021/nn103265h10.1021/nn103265h ↗
59. a)E.Murray S.Sayyar B. C.Thompson R.Gorkin D. L.Officer G. G.Wallace unpublished;
60. Sayyar S. · Mater. Sci. Forum · 2014 · 773 · 496
61. 10.1039/C4TB01636J10.1039/C4TB01636J ↗
62. 10.1016/j.carbon.2012.09.03110.1016/j.carbon.2012.09.031 ↗
63. 10.1039/B610522J10.1039/B610522J ↗
64. 10.2217/nnm.12.6010.2217/nnm.12.60 ↗
65. 10.1038/nrc254410.1038/nrc2544 ↗
66. 10.1002/adfm.20130176010.1002/adfm.201301760 ↗
67. 10.1166/jnn.2012.637310.1166/jnn.2012.6373 ↗
68. 10.4014/jmb.1212.1200510.4014/jmb.1212.12005 ↗
69. 10.1002/adma.20110150310.1002/adma.201101503 ↗
70. 10.3390/nano402050810.3390/nano4020508 ↗
71. 10.1016/j.addr.2013.10.00410.1016/j.addr.2013.10.004 ↗
72. 10.1016/j.addr.2013.07.01910.1016/j.addr.2013.07.019 ↗
73. 10.1002/smll.20120141710.1002/smll.201201417 ↗
74. 10.1007/s11671-010-9751-610.1007/s11671-010-9751-6 ↗
75. 10.1016/j.carbon.2010.11.00510.1016/j.carbon.2010.11.005 ↗
76. 10.1002/adhm.20120024810.1002/adhm.201200248 ↗
77. 10.1016/j.biomaterials.2011.08.06510.1016/j.biomaterials.2011.08.065 ↗
78. 10.3171/2013.1.PEDS1237410.3171/2013.1.PEDS12374 ↗
79. 10.1002/adhm.20120034710.1002/adhm.201200347 ↗
80. 10.1038/srep0160410.1038/srep01604 ↗
81. 10.1093/toxsci/kfr33210.1093/toxsci/kfr332 ↗
82. 10.1016/j.biomaterials.2012.11.05210.1016/j.biomaterials.2012.11.052 ↗
83. 10.1039/c1nr10172b10.1039/c1nr10172b ↗
84. 10.2147/IJN.S2339210.2147/IJN.S23392 ↗
85. 10.1002/adma.20120453010.1002/adma.201204530 ↗
86. 10.1166/jbn.2013.151110.1166/jbn.2013.1511 ↗
87. 10.1016/j.carbon.2011.06.00610.1016/j.carbon.2011.06.006 ↗
88. 10.1248/yakushi.12-00244-110.1248/yakushi.12-00244-1 ↗
89. 10.1039/c2tx20006f10.1039/c2tx20006f ↗
90. 10.1016/j.carbon.2011.05.05610.1016/j.carbon.2011.05.056 ↗
91. 10.1021/nn101187z10.1021/nn101187z ↗
92. 10.1016/j.imlet.2012.10.00110.1016/j.imlet.2012.10.001 ↗
93. 10.1016/j.biomaterials.2013.01.00110.1016/j.biomaterials.2013.01.001 ↗
94. 10.1016/j.biomaterials.2013.01.01010.1016/j.biomaterials.2013.01.010 ↗
95. 10.1039/c2nr31040f10.1039/c2nr31040f ↗
96. 10.1002/jbm.a.3114310.1002/jbm.a.31143 ↗
97. 10.1126/science.106740410.1126/science.1067404 ↗
98. 10.1302/0301-620X.94B8.2835010.1302/0301-620X.94B8.28350 ↗
99. 10.1016/j.oooo.2011.10.03610.1016/j.oooo.2011.10.036 ↗
100. 10.1039/c3tb00531c10.1039/c3tb00531c ↗